homocysteine has been researched along with tolbutamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brennan, L; Flatt, PR; McClenaghan, NH; Newsholme, P; Patterson, S | 1 |
| Flatt, PR; McClenaghan, NH; Patterson, S | 1 |
2 other study(ies) available for homocysteine and tolbutamide
| Article | Year |
|---|---|
Detrimental actions of metabolic syndrome risk factor, homocysteine, on pancreatic beta-cell glucose metabolism and insulin secretion.
Topics: Alanine; Arginine; Calcium; Carbachol; Clone Cells; Colforsin; Culture Media; Dose-Response Relationship, Drug; Gastrointestinal Hormones; Glucose; Homocysteine; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Keto Acids; Metabolic Syndrome; Potassium Chloride; Tetradecanoylphorbol Acetate; Tolbutamide | 2006 |
Homocysteine-induced impairment of insulin secretion from clonal pancreatic BRIN-BD11 beta-cells is not prevented by catalase.
Topics: Amino Acids; Animals; Calcium; Carcinogens; Catalase; Cell Line; Clone Cells; Colforsin; Dose-Response Relationship, Drug; Glucose; Homocysteine; Hydrogen Peroxide; Hypoglycemic Agents; Insulin; Insulin Secretion; Insulin-Secreting Cells; Keto Acids; Oxidation-Reduction; Potassium Chloride; Rats; Tetradecanoylphorbol Acetate; Tolbutamide | 2007 |